Penetration in cerebrospinal fluid and use of ceftaroline in ventriculitis associated with external ventricular drainage
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia - 37(2024), 2 vom: 12. März, Seite 189-190 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Penetración en líquido cefalorraquídeo y uso de ceftarolina en ventriculitis asociada a drenaje ventricular externo |
|---|
| Beteiligte Personen: |
Ramos, I [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Bacterial Agents |
|---|
| Anmerkungen: |
Date Completed 08.03.2024 Date Revised 20.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.37201/req/131.2023 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368386163 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368386163 | ||
| 003 | DE-627 | ||
| 005 | 20240320234211.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240213s2024 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.37201/req/131.2023 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1337.xml |
| 035 | |a (DE-627)NLM368386163 | ||
| 035 | |a (NLM)38348486 | ||
| 035 | |a (PII)ramos13feb2024 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Ramos, I |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Penetration in cerebrospinal fluid and use of ceftaroline in ventriculitis associated with external ventricular drainage |
| 246 | 3 | 3 | |a Penetración en líquido cefalorraquídeo y uso de ceftarolina en ventriculitis asociada a drenaje ventricular externo |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.03.2024 | ||
| 500 | |a Date Revised 20.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Ceftaroline | |
| 650 | 4 | |a Staphylococcus epidermidis | |
| 650 | 4 | |a neurosurgical central nervous system infections | |
| 650 | 7 | |a Ceftaroline |2 NLM | |
| 650 | 7 | |a H36Z0FHR8K |2 NLM | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 700 | 1 | |a Benítez-Cano, A |e verfasserin |4 aut | |
| 700 | 1 | |a Luque, S |e verfasserin |4 aut | |
| 700 | 1 | |a Sorlí, L |e verfasserin |4 aut | |
| 700 | 1 | |a Adalia, R |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia |d 1997 |g 37(2024), 2 vom: 12. März, Seite 189-190 |w (DE-627)NLM090649028 |x 1988-9518 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2024 |g number:2 |g day:12 |g month:03 |g pages:189-190 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.37201/req/131.2023 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2024 |e 2 |b 12 |c 03 |h 189-190 | ||